Novonesis A/S (NSIS-B.CO) Stock Price

Novonesis is a biosolutions company that uses microbiology and science to change how the world produces, consumes and lives. Its website presents the company as a biosolutions partner, and its registered address is in Bagsværd, Denmark. The Novonesis name came about when the combination of Novozymes and Chr. Hansen was completed in January 2024.

According to the company's own history, Chr. Hansen dates back to 1874, while Novozymes was established in 2000 as an independent company after being spun off from Novo Nordisk. Novonesis consists of two divisions, described as supporting healthier lives and a healthier planet. Its application areas cover biosolutions for food and beverages, human health and planetary health, and the industries it lists include bioenergy, industrial bioprocessing, household care, and animal and plant. Its shares trade on Nasdaq Copenhagen, with the B share under the code NSIS B. The share capital consists of A and B shares, and an A share carries more votes than a B share.

Those following Novonesis stock usually watch demand in customer industries such as food, agriculture and bioenergy, new biosolution applications, the progress of integration after the combination and the company's distributions to shareholders. On the Lzzo.com Novonesis page, the price of the Copenhagen-listed shares appears with its observation time, together with a price history chart and technical indicators.